2022 annual financial data
NewAmsterdam Pharma 2022 Net margin
Direct answer
Net margin was -22.04%.
Operating income was -3,557,000 EUR and net income was -22,634,000 EUR.
Operating cash flow was 10,665,000 EUR.
Get free NewAmsterdam Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 102,694,000 EUR
- Operating income
- -3,557,000 EUR
- Net income
- -22,634,000 EUR
- Operating cash flow
- 10,665,000 EUR